Common Contracts

18 similar Credit Agreement contracts by ArcherDX, Inc., BioXcel Therapeutics, Inc., Harrow Health, Inc., others

CREDIT AGREEMENT AND GUARANTY dated as of August 9, 2024 by and among SCPHARMACEUTICALS INC., as the Borrower, THE SUBSIDIARY GUARANTORS FROM TIME TO TIME PARTY HERETO, as the Guarantors, THE LENDERS FROM TIME TO TIME PARTY HERETO as the Lenders, and...
Credit Agreement • August 12th, 2024 • scPharmaceuticals Inc. • Pharmaceutical preparations • New York

CREDIT AGREEMENT AND GUARANTY, dated as of August 9, 2024 (this “Agreement”), among SCPHARMACEUTICALS INC., a Delaware corporation (the “Borrower”), certain Subsidiaries of the Borrower that may be required to provide Guarantees from time to time hereunder (each a “Guarantor” and collectively, the “Guarantors”), the lenders from time to time party hereto (each a “Lender” and collectively, the “Lenders”), and PERCEPTIVE CREDIT HOLDINGS IV, LP, a Delaware limited partnership, as administrative agent for the Lenders (in such capacity, together with its successors and assigns, the “Administrative Agent”).

AutoNDA by SimpleDocs
SECOND AMENDMENT TO CREDIT AGREEMENT
Credit Agreement • June 6th, 2024 • Marinus Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

This SECOND AMENDMENT TO CREDIT AGREEMENT, dated as of June 6, 2024 (this “Amendment”), to that certain Credit Agreement dated as of May 11, 2021 (as amended by the Limited Consent and First Amendment to Credit Agreement, dated as of October 28, 2022, and as further amended, modified and restated from time to time prior to the date hereof, the “Existing Credit Agreement” and, the Existing Credit Agreement, as amended by this Amendment, the “Credit Agreement”), by and among MARINUS PHARMACEUTICALS, INC., a Delaware corporation (“Borrower”), certain Subsidiaries of the Borrower that may be required to provide Guarantees from time to time thereunder (each a “Guarantor” and collectively, the “Guarantors”), the lenders from time to time thereunder (each a “Lender” and collectively, the “Lenders”), and OAKTREE FUND ADMINISTRATION, LLC, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”) is entered into by and among the Borrower, the Administrative Agent and

SECOND AMENDMENT TO CREDIT AGREEMENT AND GUARANTY AND TERMINATION OF REVENUE INTEREST FINANCING AGREEMENT
Credit Agreement • February 8th, 2024 • BioXcel Therapeutics, Inc. • Pharmaceutical preparations • New York

CREDIT AGREEMENT AND GUARANTY, dated as of April 19, 2022, and amended as of November 13, 2023 and December 5, 2023 (this “Agreement”), among BIOXCEL THERAPEUTICS, INC., a Delaware corporation (the “Borrower”), certain Subsidiaries of the Borrower that may be required to provide Guarantees from time to time hereunder (each a “Guarantor” and collectively, the “Guarantors”), the lenders from time to time party hereto (each a “Lender” and collectively, the “Lenders”), and OAKTREE FUND ADMINISTRATION, LLC, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”).

CREDIT AGREEMENT AND GUARANTY dated as of September 7, 2023 by and among FRACTYL HEALTH, INC., as the Borrower, THE SUBSIDIARY GUARANTORS FROM TIME TO TIME PARTY HERETO, as the Guarantors, THE LENDERS FROM TIME TO TIME PARTY HERETO as the Lenders, and...
Credit Agreement • December 14th, 2023 • Fractyl Health, Inc. • Surgical & medical instruments & apparatus • New York

CREDIT AGREEMENT AND GUARANTY, dated as of September 7, 2023 (this “Agreement”), among FRACTYL HEALTH, INC., a Delaware corporation (the “Borrower”), certain Subsidiaries of the Borrower that may be required to provide Guarantees from time to time hereunder (each a “Guarantor” and collectively, the “Guarantors”), SYMBIOTIC CAPITAL OPPORTUNITIES HOLDING, L.P., as a lender (“Symbiotic”), the other lenders from time to time party hereto (together with Symbiotic, each a “Lender” and collectively, the “Lenders”), and SYMBIOTIC CAPITAL AGENCY LLC, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”).

CREDIT AGREEMENT AND GUARANTY dated as of November 8, 2023 between APYX MEDICAL CORPORATION as the Borrower, THE SUBSIDIARY GUARANTORS FROM TIME TO TIME PARTY HERETO, as the Subsidiary Guarantors, THE LENDERS FROM TIME TO TIME PARTY HERETO, as the...
Credit Agreement • November 9th, 2023 • Apyx Medical Corp • Surgical & medical instruments & apparatus • New York

Credit Agreement and Guaranty, dated as of November 8, 2023 (this “Agreement”), among Apyx Medical Corporation, a Delaware corporation (the “Borrower”), the Subsidiary Guarantors from time to time parties hereto, Perceptive Credit Holdings IV, LP, a Delaware limited partnership (the “Initial Lender”), and each other lender that may from time to time become a party hereto (each, including the Initial Lender, together with their permitted successors and assigns, a “Lender” and collectively, the “Lenders”), and Perceptive Credit Holdings IV, LP, a Delaware limited partnership, as administrative agent for the Lenders (in such capacity, together with its successors and assigns, the “Administrative Agent”).

FIRST AMENDMENT TO CREDIT AGREEMENT AND GUARANTY AND CONSENT
Credit Agreement • August 9th, 2023 • Harrow Health, Inc. • Pharmaceutical preparations • New York

CREDIT AGREEMENT AND GUARANTY, dated as of March 27, 2023 (this “Agreement”), among HARROW HEALTH, INC., a Delaware corporation (the “Borrower”), certain Subsidiaries of the Borrower required to provide Guarantees from time to time hereunder, the lenders from time to time party hereto (each a “Lender” and collectively, the “Lenders”), and OAKTREE FUND ADMINISTRATION, LLC, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”).

CREDIT AGREEMENT AND GUARANTY dated as of March 27, 2023 by and among HARROW HEALTH, INC., as the Borrower, THE SUBSIDIARY GUARANTORS FROM TIME TO TIME PARTY HERETO, as the Guarantors, THE LENDERS FROM TIME TO TIME PARTY HERETO, as the Lenders, and...
Credit Agreement • May 11th, 2023 • Harrow Health, Inc. • Pharmaceutical preparations • New York

CREDIT AGREEMENT AND GUARANTY, dated as of March 27, 2023 (this “Agreement”), among HARROW HEALTH, INC., a Delaware corporation (the “Borrower”), certain Subsidiaries of the Borrower required to provide Guarantees from time to time hereunder, the lenders from time to time party hereto (each a “Lender” and collectively, the “Lenders”), and OAKTREE FUND ADMINISTRATION, LLC, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”).

CREDIT AGREEMENT AND GUARANTY dated as of April 27, 2023 by and among SERES THERAPEUTICS, INC., as the Borrower, THE SUBSIDIARY GUARANTORS FROM TIME TO TIME PARTY HERETO, as the Guarantors, THE LENDERS FROM TIME TO TIME PARTY HERETO as the Lenders,...
Credit Agreement • April 27th, 2023 • Seres Therapeutics, Inc. • Pharmaceutical preparations • New York

CREDIT AGREEMENT AND GUARANTY, dated as of April 27, 2023 (this “Agreement”), among SERES THERAPEUTICS, INC., a Delaware corporation (the “Borrower”), certain Subsidiaries of the Borrower that may be required to provide Guarantees from time to time hereunder (each a “Guarantor” and collectively, the “Guarantors”), the lenders from time to time party hereto (each a “Lender” and collectively, the “Lenders”), and OAKTREE FUND ADMINISTRATION, LLC, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”).

CREDIT AGREEMENT AND GUARANTY dated as of October 13, 2022 by and among SCPHARMACEUTICALS INC., as the Borrower, THE SUBSIDIARY GUARANTORS FROM TIME TO TIME PARTY HERETO, as the Guarantors, THE LENDERS FROM TIME TO TIME PARTY HERETO as the Lenders,...
Credit Agreement • October 14th, 2022 • scPharmaceuticals Inc. • Pharmaceutical preparations • New York

CREDIT AGREEMENT AND GUARANTY, dated as of October 13, 2022 (this “Agreement”), among SCPHARMACEUTICALS INC., a Delaware corporation (the “Borrower”), certain Subsidiaries of the Borrower that may be required to provide Guarantees from time to time hereunder (each a “Guarantor” and collectively, the “Guarantors”), the lenders from time to time party hereto (each a “Lender” and collectively, the “Lenders”), and OAKTREE FUND ADMINISTRATION, LLC, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”).

CREDIT AGREEMENT AND GUARANTY
Credit Agreement • May 16th, 2022 • Impel Pharmaceuticals Inc • Pharmaceutical preparations • New York
Certain information in this document has been excluded pursuant to Regulation S-K, Item (601)(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.
Credit Agreement • March 23rd, 2021 • Zymergen Inc. • Services-commercial physical & biological research • New York

Exhibit D-1 - Form of U.S. Tax Compliance Certificate (For Foreign Lenders That Are Not Partnerships for U.S. Federal Income Tax Purposes)

Certain information in this document has been excluded pursuant to Regulation S-K, Item (601)(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.
Credit Agreement • March 9th, 2021 • Zymergen Inc. • Services-commercial physical & biological research • New York

Exhibit D-1 - Form of U.S. Tax Compliance Certificate (For Foreign Lenders That Are Not Partnerships for U.S. Federal Income Tax Purposes)

CREDIT AGREEMENT AND GUARANTY
Credit Agreement • June 5th, 2020 • ArcherDX, Inc. • In vitro & in vivo diagnostic substances • New York

CREDIT AGREEMENT AND GUARANTY, dated as of May 10, 2019 (this “Agreement”), by and among ArcherDX, Inc., a Delaware corporation (the “Borrower”), certain Subsidiaries of the Borrower from time to time party hereto, Perceptive Credit Holdings II, LP and each other lender that may from time to time become a party hereto (each a “Lender” and collectively, the “Lenders”), and Perceptive Credit Holdings II, LP, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”).

CREDIT AGREEMENT AND GUARANTY
Credit Agreement • April 21st, 2020 • ArcherDX, Inc. • In vitro & in vivo diagnostic substances • New York

CREDIT AGREEMENT AND GUARANTY, dated as of May 10, 2019 (this “Agreement”), by and among ArcherDX, Inc., a Delaware corporation (the “Borrower”), certain Subsidiaries of the Borrower from time to time party hereto, Perceptive Credit Holdings II, LP and each other lender that may from time to time become a party hereto (each a “Lender” and collectively, the “Lenders”), and Perceptive Credit Holdings II, LP, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”).

CREDIT AGREEMENT AND GUARANTY dated as of February 11, 2019 by and among ADMA BIOLOGICS, INC., as the Borrower, THE SUBSIDIARY GUARANTORS FROM TIME TO TIME PARTY HERETO, as the Guarantors, THE LENDERS FROM TIME TO TIME PARTY HERETO as the Lenders, and...
Credit Agreement • February 12th, 2019 • Adma Biologics, Inc. • Biological products, (no disgnostic substances) • New York

Credit Agreement and Guaranty, dated as of February 11, 2019 (this “Agreement”), among ADMA BIOLOGICS, INC., a Delaware corporation (the “Borrower”), certain Subsidiaries of the Borrower that may be required to provide Guarantees from time to time hereunder (each a “Guarantor” and collectively, the “Guarantors”), the lenders from time to time party hereto (each a “Lender” and collectively, the “Lenders”), and PERCEPTIVE CREDIT HOLDINGS II, LP, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!